The effectiveness of nirsevimab in reducing the burden of disease due to respiratory syncytial virus (RSV) infection over time in the Madrid region (Spain): a prospective population-based cohort study

  1. Barbas Del Buey, J.F.
  2. Íñigo Martínez, J.
  3. Gutiérrez Rodríguez, M.Á.
  4. Alonso García, M.
  5. Sánchez-Gómez, A.
  6. Lasheras Carbajo, M.D.
  7. Jiménez Bueno, S.
  8. Esteban Vasallo, M.D.
  9. López Zambrano, M.A.
  10. Calvo Rey, C.
  11. Sanchez Luna, M.
  12. Molina Olivas, M.
  13. Arce Arnáez, M.A.
Aldizkaria:
Frontiers in Public Health

ISSN: 2296-2565

Argitalpen urtea: 2024

Alea: 12

Mota: Artikulua

DOI: 10.3389/FPUBH.2024.1441786 GOOGLE SCHOLAR lock_openSarbide irekia editor